Joseph A. Fix
21Patents
14h-index
16Co-inventors
78Inventor score
Filing activity: Dec 30, 1981 → Jul 16, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6419954B1 | Tablets and methods for modified release of hydrophilic and other active agents | Human Necessities | 235 | Expired |
| US4440740A | .alpha.-Keto aldehydes as enhancing agents of gastro-intestinal drug absorption | Human Necessities | 44 | Expired |
| US6465009B1 | Water soluble polymer-based rapidly dissolving tablets and production processes thereof | Human Necessities | 37 | Expired |
| US4537772A | Enhancing absorption of drugs from gastrointestinal tract using acylcarnitines | Emerging Cross-Sectional Technologies | 31 | Expired |
| US4692441A | Chorine esters as absorption-enhancing agents for drug delivery through mucous membranes of the nasal, buccal, sublingual and vaginal cavities | Emerging Cross-Sectional Technologies | 24 | Expired |
| US4425337A | Adjuvants for rectal delivery of drug | Human Necessities | 22 | Expired |
| US4729989A | Enhancement of absorption of drugs from gastrointestinal tract using choline ester salts | Emerging Cross-Sectional Technologies | 21 | Expired |
| US4822773A | Enhancement of absorption of drugs from gastrointestinal tract using choline ester salts | Emerging Cross-Sectional Technologies | 21 | Expired |
| US4847298A | Acylcarnitines as absorption-enhancing agents for drug delivery through mucous membranes of the nasal, buccal, sublingual and vaginal compartments | Human Necessities | 20 | Expired |
| US4731360A | Acylcarnitines as absorption-enhancing agents for drug delivery through mucous membranes of the nasal, buccal, sublingual and vaginal compartments | Human Necessities | 20 | Expired |
| US4963556A | Choline esters as absorption-enhancing agents for drug delivery through mucous membranes of the nasal, buccal, sublingual and vaginal cavities | Human Necessities | 18 | Expired |
| US4835138A | Choline esters as absorption-enhancing agents for drug delivery through mucous membranes of the nasal, buccal, sublingual and vaginal cavities | Emerging Cross-Sectional Technologies | 17 | Expired |
| US4749694A | Novel lysine esters used as absorption | Human Necessities | 15 | Expired |
| US4963525A | Acylcarnitines as absorption-enhancing agents for drug delivery through mucous membranes of the nasal, buccal, sublingual and vaginal compartments | Human Necessities | 14 | Expired |
| US4973579A | Enhancment of absorption of drugs from gastrointestinal tract using choline ester salts | Human Necessities | 12 | Expired |
| US6413546B1 | Tablets incorporating isoflavone plant extracts and methods of manufacturing them | Human Necessities | 8 | Expired |
| US6669956B2 | Tablets incorporating isoflavone plant extracts and methods of manufacturing them | Human Necessities | 4 | Expired |
| US9675585B1 | Extended release pharmaceutical formulations | Human Necessities | 2 | Active |
| US11419868B2 | Low dose product and method for treating diarrhea | Human Necessities | 0 | Active |
| US9687475B1 | Extended release pharmaceutical formulations with controlled impurity levels | Human Necessities | 0 | Active |
| US10010529B2 | Extended release pharmaceutical formulations with controlled impurity levels | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.